These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7207216)
1. Plasma levels of ethinyl oestradiol and norgestrel during hormone replacement therapy. Dennerstein L; Fotherby K; Burrows GD; Laby B; Wood C Maturitas; 1980 Jul; 2(2):147-54. PubMed ID: 7207216 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
3. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version. Carlborg L Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925 [TBL] [Abstract][Full Text] [Related]
4. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis. Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162 [TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled trial of ethinyl oestradiol and norethisterone in climacteric women. Nordin BE; Jones MM; Crilly RG; Marshall DH; Brooke R Maturitas; 1980 Oct; 2(3):247-51. PubMed ID: 7003315 [TBL] [Abstract][Full Text] [Related]
6. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women. Prasad RN; Liew D; Ratnam SS Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321 [TBL] [Abstract][Full Text] [Related]
7. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol. Miller JF; Fotherby K; Bye PG; Elstein M Contraception; 1979 Jul; 20(1):5-10. PubMed ID: 573191 [TBL] [Abstract][Full Text] [Related]
8. Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal women. Entezami M; Heger-Mahn D; Ebert A; Halis G; Lübbert H Contraception; 1997 Sep; 56(3):181-3. PubMed ID: 9347210 [TBL] [Abstract][Full Text] [Related]
9. d-Norgestrel concentrations in maternal plasma, milk, and child plasma during administration of oral contraceptives to nursing women. Nilsson S; Nygren KG; Johansson ED Am J Obstet Gynecol; 1977 Sep; 129(2):178-84. PubMed ID: 900181 [TBL] [Abstract][Full Text] [Related]
10. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen. Wilson ES; Cruickshank J; McMaster M; Weir RJ Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589 [TBL] [Abstract][Full Text] [Related]
11. Gonadotropin and estradiol secretion during the week of placebo therapy in oral contraceptive pill users. van der Spuy ZM; Sohnius U; Pienaar CA; Schall R Contraception; 1990 Dec; 42(6):597-609. PubMed ID: 2128047 [TBL] [Abstract][Full Text] [Related]
13. Levels of contraceptive seroids in breast milk and plasma of lactating women. Saxena BN; Shrimanker K; Grudzinskas JG Contraception; 1977 Dec; 16(6):605-13. PubMed ID: 606500 [TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic effects of ethinyl estradiol in women using vaginal devices releasing small doses of levonorgestrel at a constant rate. Toddyvalla V; Johannisson E; Landgren BM; Cekan SZ; Diczfalusy E Contraception; 1983 Jul; 28(1):21-39. PubMed ID: 6414759 [TBL] [Abstract][Full Text] [Related]
15. Effect of contraceptive steroids on serum levels of sex hormone binding globulin and caeruloplasmin. Limpongsanurak S; Jenkins N; Fotherby K Curr Med Res Opin; 1981; 7(3):185-91. PubMed ID: 7194172 [TBL] [Abstract][Full Text] [Related]
16. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids. Scott JA; Brenner PF; Kletzky OA; Mishell DR Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817 [TBL] [Abstract][Full Text] [Related]
17. Oral contraceptives, lipoproteins, and atherosclerosis. Adams MR; Clarkson TB; Shively CA; Parks JS; Kaplan JR Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1388-93. PubMed ID: 2220963 [TBL] [Abstract][Full Text] [Related]
18. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate. Klove KL; Roy S; Lobo RA Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099 [TBL] [Abstract][Full Text] [Related]
19. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
20. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]